Myriad Genetics Inc MYGN

Name: Myriad Genetics Inc
SKU: MYGN
Price: 5.34 USD
Availability: InStock

‎$‎5.34-0.13(-2.38%)(1D)

• Delayed prices by NASDAQ • in USD

Invest in Myriad Genetics Inc
Today

Create an eToro account to buy MYGN stock on a secure, user-friendly, multi-asset trading platform.

Myriad Genetics Inc MYGN

Buy MYGN

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Columbia Financial Inc

Myriad Genetics Inc News

Myriad Genetics (MYGN) Outlines Launch Plan for Precise MRD Assay

Myriad Genetics Inc at JPMorgan Healthcare Conference Transcript

MAX

*Past performance is not an indication of future results

Jump to:

About MYGN >
How to Buy? >
News >
Top Guides >

The Myriad Genetics Inc share price is on the decline this week.

The Myriad Genetics Inc share price today is ‎$‎5.34, reflecting a ‎-2.38‎% change over the last 24 hours and ‎-6.82‎% over the past week. The current market capitalization of MYGN is ‎$‎497.76M with an average volume in the last three months of 1.04M. The stock has a P/E ratio of -1.23 and a dividend yield of 0%. With the stock’s beta sitting at 1.21

MYGN Key Metrics

Market Cap

‎$‎497.76M

Day’s Range

‎$‎5.31 - ‎$‎5.66

52W Range

‎$‎3.74 - ‎$‎29.23

Average Volume (3M)

1.04M

Price-Earnings Ratio

-1.23

Revenue

‎$‎825.3M

Dividend (Yield)

‎$‎0 (0%)

Prev Close

‎$‎5.34

EPS

‎$‎-4.33

Beta

1.21

How can I buy Myriad Genetics Inc stocks?

To purchase Myriad Genetics Inc:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Myriad Genetics Inc (MYGN) page and place an order to buy Myriad Genetics Inc.

Buy MYGN

Looking for more information? Check out our guide on Academy.

What Is Myriad Genetics Inc?

Myriad Genetics, Inc. is an esteemed company specialising in the cutting-edge field of molecular diagnostic testing. Its operations extend globally. The firm provides genetic, molecular and companion diagnostic testing services.

As a global leader in personalised medicine, Myriad Genetics pioneers its work in the healthcare industry with high-quality diagnostic tools and gene tests. The company specialises in hereditary cancer risk, reproductive health, oncology, urology and mental health. Myriad Genetics is known for BRACAnalysis CDx, EndoPredict and Foresight.

Monitor the MYGN share price by adding it to your eToro watchlist.

CEO

Samraat S Raha, MBA

Employees

2.7K

Founded

1991

Salt Lake City, Utah, US

Med Tech

NASDAQ

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Myriad Genetics Inc
Today

Create an eToro account to buy MYGN stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Myriad Genetics Inc stock?

The current price of MYGN is ‎$‎5.34.

What are analysts’ forecasts for Myriad Genetics Inc?

Analysts offer forecasts for Myriad Genetics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Myriad Genetics Inc?

The market capitalisation of Myriad Genetics Inc is ‎$‎497.76M

Daily Movers

Explore the biggest stocks movers on the market.